Germany
Japan
United Kingdom
China
Lenti ORF particles, CD38 (Myc-DDK tagged) - Human CD38 molecule (CD38), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Products
USD 1,020.00
3 Weeks
Lenti ORF particles, PVRL4 (mGFP-tagged) - Human poliovirus receptor-related 4 (PVRL4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, SLC3A2 (mGFP-tagged) - Human solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 (SLC3A2), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,152.00
3 Weeks
Lenti ORF particles, TGFBR2 (Myc-DDK tagged) - Human transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,152.00
3 Weeks
Lenti ORF particles, TGFBR2 (mGFP-tagged) - Human transforming growth factor, beta receptor II (70/80kDa) (TGFBR2), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, FUT8 (mGFP-tagged) - Human fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (FUT8), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
ROR1 (untagged)-Human receptor tyrosine kinase-like orphan receptor 1 (ROR1), transcript variant 1
| Vector | pCMV6-XL6 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
HTR2A (untagged)-Human 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A), transcript variant 1
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
FCGR1A (untagged)-Human Fc fragment of IgG, high affinity Ia, receptor (CD64) (FCGR1A)
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
P2RX4 (untagged)-Human purinergic receptor P2X, ligand-gated ion channel, 4 (P2RX4)
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
SC122124 is the updated version of SC121945.
ORAI1 (untagged)-Human ORAI calcium release-activated calcium modulator 1 (ORAI1)
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
Lenti ORF particles, TNFRSF1A (Myc-DDK tagged) - Human tumor necrosis factor receptor superfamily, member 1A (TNFRSF1A), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, PERP (Myc-DDK tagged) - Human PERP, TP53 apoptosis effector (PERP), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, C10orf54 (mGFP-tagged) - Human chromosome 10 open reading frame 54 (C10orf54), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, SDC4 (Myc-DDK tagged) - Human syndecan 4 (SDC4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, SDC4 (mGFP-tagged) - Human syndecan 4 (SDC4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, BST2 (Myc-DDK tagged) - Human bone marrow stromal cell antigen 2 (BST2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, BST2 (mGFP-tagged) - Human bone marrow stromal cell antigen 2 (BST2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, CD200R1 (mGFP-tagged) - Human CD200 receptor 1 (CD200R1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, VSIG4 (mGFP-tagged) - Human V-set and immunoglobulin domain containing 4 (VSIG4), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, SLC34A2 (Myc-DDK tagged) - Human solute carrier family 34 (sodium phosphate), member 2 (SLC34A2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, SLC34A2 (mGFP-tagged) - Human solute carrier family 34 (sodium phosphate), member 2 (SLC34A2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,020.00
6 Weeks
Lenti ORF particles, TNFRSF25 (mGFP-tagged) - Human tumor necrosis factor receptor superfamily, member 25 (TNFRSF25), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, SLC18A2 (Myc-DDK tagged) - Human solute carrier family 18 (vesicular monoamine), member 2 (SLC18A2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, SLC18A2 (mGFP-tagged) - Human solute carrier family 18 (vesicular monoamine), member 2 (SLC18A2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, FUT8 (Myc-DDK tagged) - Human fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (FUT8), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, CLEC12A (Myc-DDK tagged) - Human C-type lectin domain family 12, member A (CLEC12A), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
CXCR7 (untagged)-Human chemokine (C-X-C motif) receptor 7 (CXCR7)
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
TLR2 (untagged)-Human toll-like receptor 2 (TLR2)
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
SLC2A1 (untagged)-Human solute carrier family 2 (facilitated glucose transporter), member 1 (SLC2A1)
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
SCARB1 (untagged)-Human scavenger receptor class B, member 1 (SCARB1), transcript variant 1
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
DPP4 (untagged)-Human dipeptidyl-peptidase 4 (DPP4)
| Vector | pCMV6-XL4 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
EPHA2 (untagged)-Human EPH receptor A2 (EPHA2)
| Vector | pCMV6-XL6 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
TNF (untagged)-Human tumor necrosis factor (TNF)
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
MET (untagged)-Human met proto-oncogene (hepatocyte growth factor receptor) (MET), transcript variant 2
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
USD 540.00
In Stock
AGTR1 (untagged)-Human angiotensin II receptor, type 1 (AGTR1), transcript variant 1
| Vector | pCMV6-XL4 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
KCNJ3 (untagged)-Human potassium inwardly-rectifying channel, subfamily J, member 3 (KCNJ3)
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
EDNRA (untagged)-Human endothelin receptor type A (EDNRA), transcript variant 1
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
ABCB1 (untagged)-Human ATP-binding cassette, sub-family B (MDR/TAP), member 1 (ABCB1)
| Vector | pCMV6-XL4 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
CTLA4 (untagged)-Human cytotoxic T-lymphocyte-associated protein 4 (CTLA4), transcript variant 1
| Vector | pCMV6-XL6 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
CANX (untagged)-Human calnexin (CANX), transcript variant 1
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
LRRC32 (untagged)-Human leucine rich repeat containing 32 (LRRC32), transcript variant 1
| Vector | pCMV6-XL6 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
KCNJ10 (untagged)-Human potassium inwardly-rectifying channel, subfamily J, member 10 (KCNJ10)
| Vector | pCMV6-XL4 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
CNR2 (untagged)-Human cannabinoid receptor 2 (macrophage) (CNR2)
| Vector | pCMV6-XL4 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
PSEN1 (untagged)-Human presenilin 1 (PSEN1), transcript variant 1
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
WNT1 (untagged)-Human wingless-type MMTV integration site family, member 1 (WNT1)
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
EGFR (untagged)-Human epidermal growth factor receptor (EGFR), transcript variant 1
| Vector | pCMV6-XL4 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
SDC1 (untagged)-Human syndecan 1 (SDC1), transcript variant 2
| Vector | pCMV6-XL4 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
KCNA3 (untagged)-Human potassium voltage-gated channel, shaker-related subfamily, member 3 (KCNA3)
| Vector | pCMV6-XL4 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
Active filters
Mammalian Cell Selection
- None
Families
- Transmembrane
Filter by
Target Symbol
- FGFR1 (23)
- NRG1 (19)
- BDNF (17)
- CD46 (15)
- DAG1 (15)
- HLA (15)
- CD44 (12)
- NTRK2 (11)
- NTRK3 (11)
- PRNP (11)
- AGTR1 (10)
- ASPH (10)
- BAX (10)
- CACNA1C (10)
- EGFR (10)
- NTRK1 (10)
- ASGR2 (9)
- FGFR2 (9)
- FGFR3 (9)
- GDNF (9)
- HGF (9)
- KREMEN1 (9)
- NRP2 (9)
- PTPRS (9)
- RTN4 (9)
- SEMA6D (9)
- SEZ6L2 (9)
- TMPRSS4 (9)
- AXL (8)
- BSG (8)
- CAV1 (8)
- CCL5 (8)
- CD22 (8)
- CDH23 (8)
- CLEC2D (8)
- CSF1 (8)
- DDR1 (8)
- DPP8 (8)
- ERBB2 (8)
- FBXW7 (8)
- GPR107 (8)
- GPR17 (8)
- IFNAR2 (8)
- MME (8)
- MUC1 (8)
- MUSK (8)
- NRG2 (8)
- PTGER3 (8)
- ROR1 (8)
- RYK (8)
- SIRPA (8)
- SLC3A2 (8)
- TRPV1 (8)
- ADGRE5 (7)
- ADGRG2 (7)
- BACE2 (7)
- BCL2 (7)
- CCR2 (7)
- CD200 (7)
- CD33 (7)
- CD36 (7)
- CD84 (7)
- CD99 (7)
- CEACAM1 (7)
- CLEC12A (7)
- CLEC4A (7)
- CNR1 (7)
- DPP10 (7)
- EGFLAM (7)
- ERBB4 (7)
- FCAR (7)
- FCRL1 (7)
- FCRLA (7)
- FLT4 (7)
- FXYD2 (7)
- GHSR (7)
- GLRA2 (7)
- GRIN1 (7)
- ICAM4 (7)
- IL1RAP (7)
- ITGB1 (7)
- KCNQ5 (7)
- LAMP2 (7)
- LPAR6 (7)
- MS4A4A (7)
- NCR1 (7)
- NRXN1 (7)
- NRXN3 (7)
- PCDH11X (7)
- PMP22 (7)
- PROM2 (7)
- PTK7 (7)
- PTPRO (7)
- SEZ6L (7)
- SLC11A2 (7)
- SLC14A1 (7)
- SLC22A6 (7)
- SLC26A11 (7)
- SLCO2B1 (7)
- SPINT1 (7)
Species
Lentivirus
Vectors
Mutants
Pathways
- Neuroactive ligand-receptor interaction (751)
- Metabolic pathways (745)
- Cytokine-cytokine receptor interaction (577)
- Cell adhesion molecules (CAMs) (435)
- Calcium signaling pathway (343)
- Pathways in cancer (341)
- Hematopoietic cell lineage (261)
- MAPK signaling pathway (249)
- Endocytosis (191)
- Regulation of actin cytoskeleton (187)
- Natural killer cell mediated cytotoxicity (171)
- Alzheimer's disease (166)
- Jak-STAT signaling pathway (157)
- Axon guidance (151)
- Dilated cardiomyopathy (151)
- Focal adhesion (149)
- Leukocyte transendothelial migration (133)
- ECM-receptor interaction (132)
- Chemokine signaling pathway (130)
- Antigen processing and presentation (126)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (126)
- Hypertrophic cardiomyopathy (HCM) (126)
- Adherens junction (122)
- Melanogenesis (120)
- Colorectal cancer (117)
- Viral myocarditis (116)
- Lysosome (113)
- Vascular smooth muscle contraction (113)
- Huntington's disease (112)
- Parkinson's disease (102)
- ABC transporters (101)
- Systemic lupus erythematosus (98)
- Graft-versus-host disease (97)
- N-Glycan biosynthesis (96)
- Wnt signaling pathway (94)
- Autoimmune thyroid disease (92)
- Oxidative phosphorylation (92)
- Apoptosis (88)
- ErbB signaling pathway (87)
- Gap junction (87)
- Prostate cancer (87)
- Allograft rejection (85)
- Neurotrophin signaling pathway (84)
- Melanoma (83)
- Toll-like receptor signaling pathway (82)
- Basal cell carcinoma (81)
- Cardiac muscle contraction (81)
- Type I diabetes mellitus (81)
- Retinol metabolism (79)
- Tight junction (77)
- Amyotrophic lateral sclerosis (ALS) (76)
- TGF-beta signaling pathway (73)
- Drug metabolism - cytochrome P450 (71)
- Adipocytokine signaling pathway (70)
- Epithelial cell signaling in Helicobacter pylori infection (70)
- Purine metabolism (70)
- PPAR signaling pathway (68)
- SNARE interactions in vesicular transport (68)
- Pancreatic cancer (67)
- Asthma (63)
- Glycerophospholipid metabolism (62)
- Sphingolipid metabolism (62)
- GnRH signaling pathway (61)
- Metabolism of xenobiotics by cytochrome P450 (60)
- Olfactory transduction (60)
- Androgen and estrogen metabolism (59)
- O-Glycan biosynthesis (58)
- Vibrio cholerae infection (58)
- Primary immunodeficiency (57)
- Starch and sucrose metabolism (57)
- Glycosphingolipid biosynthesis - lacto and neolacto series (56)
- T cell receptor signaling pathway (55)
- Long-term potentiation (54)
- Hedgehog signaling pathway (49)
- Complement and coagulation cascades (48)
- Drug metabolism - other enzymes (48)
- Taste transduction (48)
- Long-term depression (47)
- Notch signaling pathway (47)
- B cell receptor signaling pathway (46)
- Type II diabetes mellitus (45)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (44)
- Heparan sulfate biosynthesis (44)
- p53 signaling pathway (43)
- Arachidonic acid metabolism (41)
- Bladder cancer (41)
- Fc gamma R-mediated phagocytosis (41)
- Small cell lung cancer (40)
- Chronic myeloid leukemia (39)
- Renin-angiotensin system (39)
- Glycerolipid metabolism (38)
- Keratan sulfate biosynthesis (38)
- Prion diseases (38)
- Ether lipid metabolism (37)
- Porphyrin and chlorophyll metabolism (36)
- Ascorbate and aldarate metabolism (34)
- Fatty acid metabolism (34)
- Glycosphingolipid biosynthesis - ganglio series (32)
- Glioma (31)
- Glycosphingolipid biosynthesis - globo series (31)
- Pentose and glucuronate interconversions (31)
- Renal cell carcinoma (31)
- Biosynthesis of unsaturated fatty acids (30)
- Insulin signaling pathway (30)
- Progesterone-mediated oocyte maturation (30)
- Endometrial cancer (29)
- Fc epsilon RI signaling pathway (28)
- Linoleic acid metabolism (28)
- Non-small cell lung cancer (28)
- Tyrosine metabolism (28)
- Steroid biosynthesis (27)
- Chondroitin sulfate biosynthesis (26)
- Pathogenic Escherichia coli infection (26)
- Pyrimidine metabolism (25)
- Riboflavin metabolism (25)
- Nicotinate and nicotinamide metabolism (24)
- Oocyte meiosis (24)
- RIG-I-like receptor signaling pathway (24)
- Cytosolic DNA-sensing pathway (22)
- Primary bile acid biosynthesis (21)
- Thyroid cancer (21)
- Ubiquitin mediated proteolysis (21)
- Glutathione metabolism (20)
- Galactose metabolism (18)
- NOD-like receptor signaling pathway (17)
- Glycosaminoglycan degradation (16)
- Acute myeloid leukemia (15)
- Tryptophan metabolism (15)
- VEGF signaling pathway (14)
- C21-Steroid hormone metabolism (12)
- Nitrogen metabolism (12)
- alpha-Linolenic acid metabolism (12)
- Amino sugar and nucleotide sugar metabolism (11)
- Dorso-ventral axis formation (11)
- Phenylalanine metabolism (11)
- Caffeine metabolism (10)
- Glycolysis / Gluconeogenesis (10)
- Phosphatidylinositol signaling system (10)
- Propanoate metabolism (10)
- beta-Alanine metabolism (10)
- Cell cycle (9)
- Pantothenate and CoA biosynthesis (9)
- Arginine and proline metabolism (8)
- Glycine (8)
- Histidine metabolism (8)
- Inositol phosphate metabolism (8)
- Limonene and pinene degradation (8)
- Valine (8)
- leucine and isoleucine degradation (8)
- serine and threonine metabolism (8)
- Cyanoamino acid metabolism (7)
- Protein export (7)
- Pyruvate metabolism (7)
- Selenoamino acid metabolism (7)
- Taurine and hypotaurine metabolism (7)
- Terpenoid backbone biosynthesis (6)
- Butanoate metabolism (5)
- Lysine degradation (5)
- O-Mannosyl glycan biosynthesis (5)
- Other glycan degradation (5)
- Citrate cycle (TCA cycle) (4)
- Sulfur metabolism (4)
- Base excision repair (3)
- Fatty acid elongation in mitochondria (3)
- Maturity onset diabetes of the young (3)
- Ubiquinone and other terpenoid-quinone biosynthesis (3)
- Fatty acid biosynthesis (2)